Article
Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2.
Genetics - 1 Dec 2017
Ding Xia, Philip Subha, Martin Betty K, Pang Yan, Burkett Sandra, Swing Deborah A, Pamala Chinmayi, Ritt Daniel A, Zhou Ming, Morrison Deborah K, Ji Xinhua, Sharan Shyam K
Abstract excerpt
BRCA2 loss-of-heterozygosity (LOH) is frequently observed in BRCA2-mutated tumors, but its biallelic loss causes embryonic lethality in mice and inhibits proliferation of normal somatic cells. Therefore, it remains unclear how loss of BRCA2 contributes to tumorigenesis. One possibility is that mutation in potential genetic interactors of BRCA2, such as TRP53, is required for cell survival/proliferation in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
